Kim Younhee, Kim Young Woo, Choi Il Ju, Cho Joo Young, Kim Jong Hee, Kwon Jin Won, Lee Ja Youn, Lee Na Rae, Seol Sang Yong
National Evidence-Based Healthcare Collaborating Agency, Seoul and Institute of Health and Environment, Seoul National University, Seoul, Korea.
Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
Gut Liver. 2015 Mar;9(2):174-80. doi: 10.5009/gnl13299.
BACKGROUND/AIMS: This study was conducted to evaluate whether medical costs can be reduced using endoscopic submucosal dissection (ESD) instead of conventional surger-ies in patients with early gastric cancer (EGC).
Pa-tients who underwent open gastrectomy (OG), laparoscopy-assisted gastrectomy (LAG), and ESD for EGC were recruited from three medical institutions in 2009. For macro-costing, the medical costs for each patient were derived from the ex-penses incurred during the patient's hospital stay and 1-year follow-up. The overall costs in micro-costing were determined by multiplying the unit cost with the resources used during the patients' hospitalization.
A total of 194 patients were included in this study. The hospital stay for ESD was 5 to 8 days and was significantly shorter than the 12-day hospital stay for OG or the 11- to 17-day stay for LAG. Using macro-costing, the average medical costs for ESD during the hospital stay ranged from 2.1 to 3.4 million Korean Won (KRW) per patient, and the medical costs for conventional surgeries were estimated to be between 5.1 million and 8.2 million KRW. There were no significant differences in the 1-year follow-up costs between ESD and conventional surger-ies.
ESD patients had lower medical costs than those patients who had conventional surgeries for EGC with conservative indications. (Gut Liver, 2015;9174-180).
背景/目的:本研究旨在评估对于早期胃癌(EGC)患者,使用内镜黏膜下剥离术(ESD)而非传统手术是否能够降低医疗成本。
2009年从三家医疗机构招募了接受开放胃切除术(OG)、腹腔镜辅助胃切除术(LAG)以及ESD治疗EGC的患者。对于宏观成本核算,每位患者的医疗成本来自患者住院期间及1年随访所产生的费用。微观成本核算中的总成本是通过将单位成本与患者住院期间使用的资源相乘来确定的。
本研究共纳入194例患者。ESD的住院时间为5至8天,明显短于OG的12天住院时间或LAG的11至17天住院时间。采用宏观成本核算,ESD患者住院期间的平均医疗成本为每位患者210万至340万韩元(KRW),传统手术的医疗成本估计在510万至820万KRW之间。ESD与传统手术在1年随访成本方面无显著差异。
对于具有保守适应症的EGC患者,接受ESD治疗的患者医疗成本低于接受传统手术的患者。(《胃肠肝脏病学》,2015;9:174 - 180)